PERI, VERONICA
PERI, VERONICA
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience
2022-01-01 Clerico, Michele; Dogliotti, Irene; Ghione, Paola; Zilioli, Vittorio Ruggero; Merli, Francesco; Botto, Barbara; Al Essa, Wael; Battaglini, Marcella; Grimaldi, Daniele; Cervi, Loretta; Ragaini, Simone; Ferrero, Simone; Peri, Veronica; De Luca, Gabriele; Marzano, Alfredo; Cavallo, Federica
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study
2022-01-01 Varettoni, Marzia; Zibellini, Silvia; Merli, Michele; Drandi, Daniela; Jiménez, Cristina; Furlan, Daniela; Ferretti, Virginia Valeria; Fabbri, Nicole; Dogliotti, Irene; Varraso, Chiara; Ferrante, Martina; Cappello, Emilia; Peri, Veronica; Cavalloni, Chiara; Borriero, Michela; Facchetti, Giulia Vittoria; Ferrero, Simone; Arcaini, Luca; Garcia-Sanz, Ramon
Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: the STRIDER study
2024-01-01 Irene Dogliotti , Veronica Peri, Michele Clerico, Francesco Vassallo, Davide Musto, Silvio Mercadante, Simone Ragaini, Barbara Botto, Mario Levis, Mattia Novo, Marco Ghislieri, Luca Molinaro, Umberto Mortara, Chiara Consoli, Alessio Lonardo, Giulia Bondielli, Simone Ferrero, Roberto Freilone, Umberto Ricardi, Benedetto Bruno, Federica Cavallo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience | 2022 | Clerico, Michele; Dogliotti, Irene; Ghione, Paola; Zilioli, Vittorio Ruggero; Merli, Francesco; Botto, Barbara; Al Essa, Wael; Battaglini, Marcella; Grimaldi, Daniele; Cervi, Loretta; Ragaini, Simone; Ferrero, Simone; Peri, Veronica; De Luca, Gabriele; Marzano, Alfredo; Cavallo, Federica | |
| Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study | 2022 | Varettoni, Marzia; Zibellini, Silvia; Merli, Michele; Drandi, Daniela; Jiménez, Cristina; Furlan, Daniela; Ferretti, Virginia Valeria; Fabbri, Nicole; Dogliotti, Irene; Varraso, Chiara; Ferrante, Martina; Cappello, Emilia; Peri, Veronica; Cavalloni, Chiara; Borriero, Michela; Facchetti, Giulia Vittoria; Ferrero, Simone; Arcaini, Luca; Garcia-Sanz, Ramon | |
| Real life clinical outcomes of relapsed/refractory diffuse large B cell lymphoma in the rituximab era: the STRIDER study | 2024 | Irene Dogliotti , Veronica Peri, Michele Clerico, Francesco Vassallo, Davide Musto, Silvio Mercadante, Simone Ragaini, Barbara Botto, Mario Levis, Mattia Novo, Marco Ghislieri, Luca Molinaro, Umberto Mortara, Chiara Consoli, Alessio Lonardo, Giulia Bondielli, Simone Ferrero, Roberto Freilone, Umberto Ricardi, Benedetto Bruno, Federica Cavallo |